Upon activation, this axis maintains activation of miR-378a-3p biogenesis, suppression of Sort1, increased stabilization and secretion of ApoB100, which subsequently facilitates hepatic secretion of VLDL and aggravates the pathogenesis of hyperlipidemia. The gene discussed is SORT1; the disease is hyperlipidemia.